Translate

Friday, January 24, 2020

thumbnail

CRBP Corbus Pharmaceuticals Holdings, Inc. gains 21% Jan 24, 2020

Corbus Pharmaceuticals Holdings, Inc., a clinical stage pharmaceutical company, focuses on the development and commercialization of novel therapeutics to treat inflammatory and fibrotic diseases. Its lead product candidate includes JBT-101, a novel oral endocannabinoid-mimetic drug, which is in Phase 2 clinical trials for the treatment of systemic sclerosis, cystic fibrosis, diffuse cutaneous, skin-predominant dermatomyositis, and systemic lupus erythematosus diseases. The company is based in Norwood, Massachusetts.http://www.priceseries.com/trade/CRBP-Corbus-Pharmaceuticals-Holdings-Inc-stock-gains-21-percent-a-Trade-Record-by-priceSeries-2020010320200124.html

Subscribe by Email

Follow Updates Articles from This Blog via Email

No Comments

TradeVisor Product Review

Review I II III IV

Blog Archive